Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Tuberous Sclerosis × Carbamazepine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1 Multiple Endocrine Neoplasia Type 1 1 Focal Cortical Dysplasia 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Everolimus 5 Cannabidiol 4 radiprodil 3 ganaxolone 3 Sirolimus 2 Melatonin 2 exemestane 1 dactolisib 1 Solutions 1 Itraconazole 1 Injections 1 Carbamazepine 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06965881 2025-11-21

Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults

GRIN Therapeutics, Inc.

Phase 1 Terminated

Focal Cortical Dysplasia, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡